Regional Safety Officer - Nordics

The primary objective of the Regional Safety Officer position is to manage the local pharmacovigilance (PV) system(s) for CSL Behring and CSL Vifor in the Nordic Region (Sweden, Denmark, Finland, Iceland, Norway) ensuring compliance with applicable PV regulations and guidelines as well as corporate and Global Safety & Pharmacovigilance (GSPV) policies. This role is strictly non-promotional and operates in alignment with the principles of CSL's Global Safety Governance System to ensure maintenance of the company's license to operate

Responsibilities:

• Establishes and maintains local PV systems in compliance with national regulations and GSPV policies. Leverages a diverse and robust set of sources including but not limited to regulatory intelligence, continuous improvement initiatives, key performance indicators (KPIs) as well as audit / inspection findings, to evolve and enhance the local PV system.
  
• Ensures comprehensive oversight of all local pharmacovigilance (PV) activities conducted at CSL, and establishes a robust framework for assessing potential risks, monitoring trends, and managing emerging issues.
  

Responsible for the establishment, maintenance, and oversight of local Pharmacovigilance (PV) processes, including but not limited to:

• Management of Individual Case Safety Reports (ICSRs), encompassing their handling, reporting, and follow-up, as well as compliance oversight where applicable.
  
• Reconciliation of ICSRs with relevant internal stakeholders, such as Global Case Management, local Quality and Medical Information as well as third parties (e.g., distributors, Medical Information vendors, Organised Data Collection Systems (ODCS), service providers, etc.).
  
• Regular screening of local literature, ensuring that all identified safety information is managed in accordance with local and global processes.
  
• Maintains up to date information relevant for the Pharmacovigilance System Master File (PSMF) or local PSMF as required by local regulations.
  
• If applicable, oversight of the submission status of aggregate reports (e.g., PSURs) to the relevant regulatory authorities, as well as the preparation or contribution to local aggregate reports, Risk Management Plans (RMPs), and supporting documents where necessary.
  
• Implementation of additional risk minimization measures (aRMMs), where applicable.
  
• PV oversight of local digital and social media channels.
  
• Ensuring the existence and regular testing of a local PV business continuity plan.
  
• Documentation of local PV activities in appropriate procedures and records.
  
• Storage and archiving of PV-related documents and records in GXP validated repository.
  
• Conducting local reportability assessments and the reporting of signals and urgent safety information to local regulatory authorities as required.
  
• Providing guidance to deputy RSO on the execution of local PV processes.
  
• Acts as a primary point of contact for all PV-related matters in their territory/region, and timely communication and escalation of PV-relevant issues as per established local and global processes.

Responsible for ensuring awareness and compliance with current PV regulations and guidelines. Oversees the local assessment, communication, and implementation of new or updated PV requirements, including notifying Global of local reporting obligations to ensure the Global Safety Database remains compliant. Provides advice to management and updates controlled documents and platforms to align with evolving regulations.

Establishes good working relationships with GSPV, Global Regulatory Affairs (GRA) and local functions, such as Local Quality Officer (e.g., for PTCs), Marketing and Medical Affairs (e.g., for ODCSs), Commercial Operations, Research & Development Quality Assurance (R&DQA) and Clinical.

Maintains up-to-date understanding of safety profiles of registered products. If applicable, supports and collaborates with cross-functional teams to identify and investigate safety concerns, contributing to the evaluation of product safety risks.

Partakes in internal meetings regarding product safety as applicable.

If applicable and as required, participates in local Commercial Operations Leadership Team meetings as required and provides input to strategic planning discussions as needed, ensuring alignment of PV activities with broader organizational objectives.

Ensures appropriate pharmacovigilance oversight of all Organized Data Collection Systems (ODCS) within the territory, ensuring adherence to relevant processes. Facilitates the implementation of Pharmacovigilance Agreements (PVAs) in close collaboration with the relevant Global Safety and Pharmacovigilance (GSPV) functions and local teams e.g Global Pharmacovigilance Agreements and Alliance (GPAA) and International Partner Market (IPM) team.

Responsible for the management and oversight of third-party subcontracted activities, maintaining local control and accountability.

Conducts reviews of relevant Quality Agreements with business partners, ensuring pharmacovigilance obligations are incorporated into PVAs as needed in collaboration with GPAA.

Key PV point of contact for local PV inspection by competent Regulatory Authorities and/or PV affiliate audits in the territory, in collaboration with CSL QPPV, GSPV IPV, PVRQA, and relevant local functions.

Ensures audit / inspection preparation and close-out activities including the development of a CAPA plan and the close out of any audit / inspection action items.

Responsible as the follow up coordinator for CAPAs raised and for the close out of audit action items, where necessary.

Manages PV training requirements of affiliate personnel and personnel of relevant 3rd party service providers, ensuring these personnel are aware of their PV reporting obligations. This includes development of training materials with IPV, delivery of regular and ad-hoc training, and monitoring of training compliance.

Skills and Experience

• Degree in life science, nursing, pharmacy, or other related area; OR Equivalent experience
  
• Qualification in line with relevant local legislation
  
• At least 6 years' experience in the pharma industry, and knowledge in pharmacovigilance; OR Equivalent experience in line with relevant local legislation
  
• Good verbal and written communication skills in English
  
• Fluent in local language(s) of territory
  
• Travel Requirements: Domestic and/or international
  

Our Benefits

We encourage you to make your well-being a priority. It's important and so are you. Learn more about how we care at CSL.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

We want CSL to reflect the world around us

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL

Do work that matters at CSL Behring!

Client-provided location(s): Åkersberga, Sweden

Job ID: CSL_FGB-R-262980

Employment Type: FULL_TIME

Posted: 2025-10-24T23:31:43